19-8364439-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_139314.3(ANGPTL4):c.118G>A(p.Glu40Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0171 in 1,555,220 control chromosomes in the GnomAD database, including 262 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars). Synonymous variant affecting the same amino acid position (i.e. E40E) has been classified as Likely benign.
Frequency
Genomes: 𝑓 0.015 ( 30 hom., cov: 32)
Exomes 𝑓: 0.017 ( 232 hom. )
Consequence
ANGPTL4
NM_139314.3 missense
NM_139314.3 missense
Scores
2
8
8
Clinical Significance
Conservation
PhyloP100: 6.58
Genes affected
ANGPTL4 (HGNC:16039): (angiopoietin like 4) This gene encodes a glycosylated, secreted protein containing a C-terminal fibrinogen domain. The encoded protein is induced by peroxisome proliferation activators and functions as a serum hormone that regulates glucose homeostasis, lipid metabolism, and insulin sensitivity. This protein can also act as an apoptosis survival factor for vascular endothelial cells and can prevent metastasis by inhibiting vascular growth and tumor cell invasion. The C-terminal domain may be proteolytically-cleaved from the full-length secreted protein. Decreased expression of this gene has been associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. This gene was previously referred to as ANGPTL2 but has been renamed ANGPTL4. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0040303767).
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.015 (2292/152350) while in subpopulation AMR AF= 0.0236 (361/15308). AF 95% confidence interval is 0.0216. There are 30 homozygotes in gnomad4. There are 1095 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 30 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANGPTL4 | NM_139314.3 | c.118G>A | p.Glu40Lys | missense_variant | 1/7 | ENST00000301455.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANGPTL4 | ENST00000301455.7 | c.118G>A | p.Glu40Lys | missense_variant | 1/7 | 1 | NM_139314.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0151 AC: 2292AN: 152232Hom.: 30 Cov.: 32
GnomAD3 genomes
AF:
AC:
2292
AN:
152232
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0133 AC: 2016AN: 151260Hom.: 17 AF XY: 0.0130 AC XY: 1068AN XY: 82292
GnomAD3 exomes
AF:
AC:
2016
AN:
151260
Hom.:
AF XY:
AC XY:
1068
AN XY:
82292
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0174 AC: 24354AN: 1402870Hom.: 232 Cov.: 32 AF XY: 0.0171 AC XY: 11879AN XY: 693090
GnomAD4 exome
AF:
AC:
24354
AN:
1402870
Hom.:
Cov.:
32
AF XY:
AC XY:
11879
AN XY:
693090
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0150 AC: 2292AN: 152350Hom.: 30 Cov.: 32 AF XY: 0.0147 AC XY: 1095AN XY: 74496
GnomAD4 genome
AF:
AC:
2292
AN:
152350
Hom.:
Cov.:
32
AF XY:
AC XY:
1095
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
132
ExAC
AF:
AC:
918
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Plasma triglyceride level quantitative trait locus Other:1
association, no assertion criteria provided | literature only | OMIM | May 08, 2009 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;.;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;.;D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;.;M;M
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;.;.;N;N
REVEL
Benign
Sift
Uncertain
.;.;.;D;D
Sift4G
Uncertain
D;D;D;D;D
Polyphen
1.0
.;.;.;D;.
Vest4
0.39, 0.34
MPC
0.81
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at